Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Top Cited Papers
Open Access
- 24 February 2016
- journal article
- review article
- Published by Springer Nature in Molecular Cancer
- Vol. 15 (1) , 1-14
Abstract
The epithelial to mesenchymal transition (EMT) is a biological process in which a non-motile epithelial cell changes to a mesenchymal phenotype with invasive capacities. This phenomenon has been well documented in multiple biological processes including embryogenesis, fibrosis, tumor progression and metastasis. The hallmark of EMT is the loss of epithelial surface markers, most notably E-cadherin, and the acquisition of mesenchymal markers including vimentin and N-cadherin. The downregulation of E-cadherin during EMT can be mediated by its transcriptional repression through the binding of EMT transcription factors (EMT-TFs) such as SNAIL, SLUG and TWIST to E-boxes present in the E-cadherin promoter. Additionally, EMT-TFs can also cooperate with several enzymes to repress the expression of E-cadherin and regulate EMT at the epigenetic and post- translational level. In this review, we will focus on epigenetic and post- translational modifications that are important in EMT. In addition, we will provide an overview of the various therapeutic approaches currently being investigated to undermine EMT and hence, the metastatic progression of cancer as well.Keywords
This publication has 140 references indexed in Scilit:
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- Over‐expression of FoxM1 leads to epithelial–mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cellsJournal of Cellular Biochemistry, 2011
- Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor ProgressionJournal of Mammary Gland Biology and Neoplasia, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- Molecular mechanisms controlling E-cadherin expression in breast cancerBiochemical and Biophysical Research Communications, 2009
- Targeting transforming growth factor-β signaling in liver metastasis of colon cancerCancer Letters, 2009
- Sumoylation and human disease pathogenesisTrends in Biochemical Sciences, 2009
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Twist is a transcriptional repressor of E-cadherin gene expression in breast cancerBiochemical and Biophysical Research Communications, 2008
- Chromatin Modifications and Their FunctionCell, 2007